Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
446.54
+3.38 (+0.76%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
72
73
Next >
Vertex Plunges 10% After Its Non-Opioid Pain Drug Flops In Lower Back Pain
↗
December 19, 2024
The company says there was variability among placebo responses at various sites.
Via
Investor's Business Daily
Vertex Non-Opioid Drug Doesn't Best Placebo In Back Pain Study. The Stock Is Plunging.
↗
December 19, 2024
Vertex Pharmaceuticals' drug reduced back pain significantly.
Via
Investor's Business Daily
Vertex Announces Results From Phase 2 Study of Suzetrigine for the Treatment of Painful Lumbosacral Radiculopathy
December 19, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
2 Unstoppable Stocks to Buy and Hold for the Next Decade
↗
December 19, 2024
Via
The Motley Fool
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio?
↗
December 17, 2024
Via
The Motley Fool
$100 Invested In This Stock 20 Years Ago Would Be Worth This Much Today
↗
December 13, 2024
Via
Benzinga
The Ultimate Biotech Stock to Buy With $500 Right Now
↗
December 12, 2024
Via
The Motley Fool
Looking Into Vertex Pharmaceuticals's Recent Short Interest
↗
November 25, 2024
Via
Benzinga
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
↗
December 16, 2024
Via
Benzinga
Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030
↗
December 16, 2024
Via
The Motley Fool
3 Unstoppable Stocks to Buy Right Now
↗
December 15, 2024
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
December 10, 2024
Via
Benzinga
Vertex Has $5 Billion-Plus Opportunity In Pain And Kidney Disease Programs, Analyst Upgrades Stock
↗
December 09, 2024
Jefferies upgrades Vertex Pharmaceuticals to Buy, highlighting a promising pipeline and $5 billion-$7 billion growth potential from pain and kidney treatments.
Via
Benzinga
Got $500? 1 Biotech Stock to Buy and Hold Forever
↗
November 22, 2024
Via
The Motley Fool
A Closer Look at Vertex Pharmaceuticals's Options Market Dynamics
↗
November 18, 2024
Via
Benzinga
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 19 Analysts
↗
December 09, 2024
Via
Benzinga
2 No-Brainer Stocks to Buy Before the End of 2024
↗
December 09, 2024
Via
The Motley Fool
Vertex Presents Positive Long-Term Data On CASGEVY™ (exagamglogene autotemcel) at the American Society of Hematology (ASH) Annual Meeting and Exposition and Provides Program Update
December 08, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
3 No-Brainer Growth Stocks to Buy in December
↗
December 07, 2024
Via
The Motley Fool
Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?
↗
December 05, 2024
Via
The Motley Fool
FDA-Approved Sickle Cell Therapies From Bluebird Bio And Vertex Join Medicaid Innovation Program
↗
December 04, 2024
CMS launches an outcomes-based model to expand access to FDA-approved gene therapies for sickle cell disease, aiming to improve health outcomes and lower costs.
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
December 04, 2024
Via
Benzinga
It’s Been A Tough Month For Healthcare Stocks
↗
December 02, 2024
It’s been a very difficult month for the healthcare sector not only because of disappointing company news but also disruption caused by the election and future policy issues.
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
↗
November 28, 2024
Via
The Motley Fool
Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?
↗
November 24, 2024
Via
The Motley Fool
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
↗
November 18, 2024
Via
The Motley Fool
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
↗
November 16, 2024
Via
The Motley Fool
Prediction: This Biotech Stock Is Heading for a Once-in-a-Generation Opportunity
↗
November 13, 2024
Regulators are reviewing what could become a multi-billion-dollar drug.
Via
The Motley Fool
Biotech Stocks Are Rallying: What Is Your Playbook?
↗
November 11, 2024
If you have been reading our posts you know that some of the big biotech winners have taken a hit after earnings : LLY, MRK and REGN. But ABBV, GILD, LLY, and VRTX remain among the top performers.
Via
Talk Markets
Five S&P 500 Stocks, All Elite IBD Giants, Near Buy Points
↗
November 09, 2024
Meta just forged a new base. All five stocks are on the IBD Leaderboard list.
Via
Investor's Business Daily
Topics
Stocks
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
72
73
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
